Index of medicine substances

Thyme + mallow

Indicated for: cough; pharyngeal irritation

R05CA10 Respiratory system | Expectorants, excl. combinations with cough suppressants

Thyrotropin alfa

Indicated for: monitoring and diagnosis in thyroid cancer

H01AB01 Systemic hormonal preparations, excluding sex hormones and insulins | Anterior pituitary lobe hormones and analogues | Thyrotropin

Tiagabine

Indicated for: epilepsy

N03AG06 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives

Tianeptine

Indicated for: depression

N06AX14 Nervous system | Antidepressants | Other antidepressants

Tiapride

Indicated for: behavioral disorders; movement disorders

N05AL03 Nervous system | Antipsychotics | Benzamides

Tibolone

Indicated for: menopausal symptoms

G03CX01 Genito urinary system and sex hormones | Estrogens | Other estrogens

Ticagrelor

Indicated for: prevention of atherothrombotic events

B01AC24 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Ticarcillin + clavulanic acid

Indicated for: bacterial infections

J01CR03 Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors

Tick-borne encephalitis vaccine

Indicated for: prevention of tick-borne encephalitis

J07BA01 Antiinfectives for systemic use | Viral vaccines | Encephalitis vaccines

Ticlopidine

Indicated for: prevention of atherothrombotic events

B01AC05 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Tigecycline

Indicated for: bacterial infections

J01AA12 Antiinfectives for systemic use | Tetracyclines

Tildrakizumab

Indicated for: psoriasis

L04AC17 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors

Timolol

Indicated for: glaucoma; hypertension

S01ED01 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents

Tin-labeled cells

Indicated for: diagnostic imaging

V09GA06 Various | Cardiovascular system | Technetium (99mtc) compounds

Tincture of arnica flowers

Indicated for: bruises; local muscle pain

Tinidazole

Indicated for: bacterial and protozoal infections

P01AB02 Antiparasitic products, insecticides and repellents | Agents against amoebiasis and other protozoal diseases | Nitroimidazole derivatives

Tinzaparin

Indicated for: prevention and treatment of thromboembolism

B01AB10 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Heparin group

Tiotropium

Indicated for: asthma; chronic obstructive pulmonary disease

R03BB04 Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics

Tiotropium + olodaterol

Indicated for: chronic obstructive pulmonary disease

R03AL06 Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids

Tipranavir

Indicated for: HIV-1 infection

J05AE09 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Tirofiban

Indicated for: prevention of atherothrombotic events

B01AC17 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Tirzepatide

Indicated for: type 2 diabetes mellitus; weight management

A10BX16 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins

Tisagenlecleucel

Indicated for: hematologic malignancies

L01XL04 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Antineoplastic cell and gene therapy

Tislelizumab

Indicated for: cancer

L01FF09 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Tivozanib

Indicated for: cancer

L01EK03 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

Tixagevimab + cilgavimab

Indicated for: prevention of COVID-19

J06BD03 Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies

Tizanidine

Indicated for: spasticity; muscle spasms

M03BX02 Musculo-skeletal system | Muscle relaxants | Muscle relaxants, centrally acting agents | Other centrally acting agents

Tobramycin

Indicated for: bacterial infections

S01AA12 Sensory organs | Antiinfectives | Antibiotics

Tobramycin + dexamethasone

Indicated for: inflammatory dermatoses

S01CA01 Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination

Tocilizumab

Indicated for: autoimmune inflammatory diseases

L04AC07 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors